Pyridam Farma Prioritizes to Produce, Sell COVID-19 Drugs


PT Pyridam Farma Tbk (PFYA) is committed to prioritizing the production and distribution of COVID-19 therapeutic drugs, such as Azithromycin 500mg, Levofloxacin, and vitamin D3-1000.

"Covid-19 cases in Indonesia are increasing quite rapidly. Therefore, we prioritize the production and distribution of drugs and supplements that are cloudy in their recovery," said Director of PFYA, Widjanarko Brotosaputro, in his statement on Wednesday (14/7).

He added that the company will distribute 100 thousand tablets of Azithromycin 500 mg according to the highest retail price (HET) set by the government.

"Meanwhile, around 275,000 tablets are in production and we will distribute them as soon as possible," he added.

PYFA, through its consumer health products, Pyfahealth, has a variety of supplements and vitamins such as Damuvit C1000, D3-1000, D3-400, Imudator, and Pyfaton to help strengthen the immunity of the Indonesian people. People



Berita Populer


ASEANFLAG

Kategori Berita